Journal of Andrology, Vol 21, Issue 2 311-315, Copyright © 2000 by The American Society of Andrology

JOURNAL ARTICLE

Intracavernosal pressure monitoring in mice: responses to electrical stimulation of the cavernous nerve and to intracavernosal drug administration

S. F. Sezen and A. L. Burnett
Department of Urology, The Johns Hopkins Hospital, Baltimore, Maryland 21287, USA.

With the development of transgenic mice to evaluate mechanisms of erectile function, it appears particularly advantageous to develop a standardized mouse model of penile erection. The purpose of the study reported here was to evaluate the novel application of intracavernosal pressure (ICP) monitoring in the mouse during electrophysiologic and pharmacologic induction of penile erection. In anesthetized adult male mice, the cavernous nerves (CN) were isolated unilaterally, and the corpora cavernosa were exposed. A 24-gauge angiocath (intravenous catheter) was inserted into the right corpus cavernosum to monitor the ICP, and a 30.5-gauge needle was inserted into the left corpus cavernosum for intracavernosal drug administration. ICP was recorded during CN-stimulated or pharmacostimulated erections. Electrical stimulation of the CN significantly increased the ICP (from 10.09 +/- 2.01 to 34.62 +/- 2.71 mm Hg, P < .05), which then returned to baseline pressure after termination of the electrical stimulation. Pretreatment with intracavernosal administration of the nitric oxide synthase inhibitor, nitro-L-arginine methyl ester (0.1 mg), inhibited the electrical stimulation-induced changes in ICP (7.17 +/- 1.46 vs 10.38 +/- 2.17 mm Hg, not significant [NS]). Also, intracavernosal administration of papaverine (0.4 mg) produced a significant increase in ICP (from 8.51 +/- 0.69 to 26.37 +/- 5.7 mm Hg, P < .05). We concluded that this technique might be applied to perform quantitative erection physiologic experiments with the mouse as an economical and experimentally advantageous animal model, particularly with the development of transgenic mice to evaluate mechanisms of erectile function.

This article has been cited by other articles:

				T. J. Bivalacqua, A. L. Burnett, W. J. G. Hellstrom, and H. C. Champion Overexpression of arginase in the aged mouse penis impairs erectile function and decreases eNOS activity: influence of in vivo gene therapy of anti-arginase Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1340 - H1351. [Abstract] [Full Text] [PDF]

				C. Gocmen, H. S. Buyuknacar, A. Y. Kots, F. Murad, O. Kiroglu, and E. K. Kumcu The Relaxant Activity of 4,7-Dimethyl-1,2,5-oxadiazolo[3,4-d]-pyridazine 1,5,6-Trioxide in the Mouse Corpus Cavernosum J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 753 - 761. [Abstract] [Full Text] [PDF]

				M. E. Werner, P. Zvara, A. L. Meredith, R. W. Aldrich, and M. T. Nelson Erectile dysfunction in mice lacking the large-conductance calcium-activated potassium (BK) channel J. Physiol., September 1, 2005; 567(2): 545 - 556. [Abstract] [Full Text] [PDF]

				H. C. Champion, T. J. Bivalacqua, E. Takimoto, D. A. Kass, and A. L. Burnett Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism PNAS, February 1, 2005; 102(5): 1661 - 1666. [Abstract] [Full Text] [PDF]

				B. Musicki, M. A. Palese, J. K. Crone, and A. L. Burnett Phosphorylated Endothelial Nitric Oxide Synthase Mediates Vascular Endothelial Growth Factor-Induced Penile Erection Biol Reprod, February 1, 2004; 70(2): 282 - 289. [Abstract] [Full Text] [PDF]

				M. A. Palese, J. K. Crone, and A. L. Burnett A Castrated Mouse Model of Erectile Dysfunction J Androl, September 1, 2003; 24(5): 699 - 703. [Abstract] [Full Text] [PDF]

				K. J. Hurt, B. Musicki, M. A. Palese, J. K. Crone, R. E. Becker, J. L. Moriarity, S. H. Snyder, and A. L. Burnett Akt-dependent phosphorylation of endothelial nitric-oxide synthase mediates penile erection PNAS, March 19, 2002; 99(6): 4061 - 4066. [Abstract] [Full Text] [PDF]